Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSB
1801
DELISTED
Franklin Financial Network, Inc.
FSB
| $3.88M | ﹤0.01% |
150,500
-3,500
| -2% | -$81.9K |
|
1802
Vornado Realty Trust
VNO
$7.28B
| $3.87M | ﹤0.01% |
+101,399
| New | +$3.94M |
|
1803
3D Systems Corp
DDD
$616M
| $3.87M | ﹤0.01% |
553,950
-579,100
| -51% | -$4.33M |
|
1804
Magnachip Semiconductor
MX
$139M
| $3.87M | ﹤0.01% |
375,231
+268,501
| +252% | +$2.99M |
|
1805
SITE Centers
SITC
$155M
| $3.86M | ﹤0.01% |
611,467
-85,108
| -12% | -$417K |
|
1806
Texas Roadhouse
TXRH
$13.6B
| $3.85M | ﹤0.01% |
+73,172
| New | +$3.57M |
|
1807
AMN Healthcare
AMN
$1.34B
| $3.84M | ﹤0.01% |
84,900
+51,500
| +154% | +$2.46M |
|
1808
Atkore
ATKR
$3.17B
| $3.84M | ﹤0.01% |
140,300
-41,700
| -23% | -$1.03M |
|
1809
Southern First Bancshares
SFST
$608M
| $3.83M | ﹤0.01% |
138,307
-16,000
| -10% | -$434K |
|
|
KRA
1810
DELISTED
Kraton Corporation
KRA
| $3.83M | ﹤0.01% |
221,689
-81,280
| -27% | -$1.1M |
|
1811
Invesco Preferred ETF
PGX
$3.77B
| $3.82M | ﹤0.01% |
+270,300
| New | +$3.79M |
|
1812
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.76B
| $3.81M | ﹤0.01% |
+62,900
| New | +$3.45M |
|
1813
Digi International
DGII
$3.23B
| $3.8M | ﹤0.01% |
326,384
-205,716
| -39% | -$2.2M |
|
|
ORTX
1814
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.78M | ﹤0.01% |
63,040
+37,320
| +145% | +$3.42M |
|
1815
Interface
TILE
$2.19B
| $3.78M | ﹤0.01% |
464,406
+180,400
| +64% | +$1.53M |
|
1816
Cathay General Bancorp
CATY
$4.33B
| $3.78M | ﹤0.01% |
143,671
-7,000
| -5% | -$179K |
|
1817
Citizens & Northern Corp
CZNC
$466M
| $3.78M | ﹤0.01% |
182,900
-22,500
| -11% | -$425K |
|
1818
iQIYI
IQ
$1.3B
| $3.76M | ﹤0.01% |
162,000
-111,300
| -41% | -$2.06M |
|
1819
Lexicon Pharmaceuticals
LXRX
$1.03B
| $3.75M | ﹤0.01% |
1,880,203
+213,605
| +13% | +$419K |
|
|
BLPH
1820
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $3.74M | ﹤0.01% |
298,111
+148,930
| +100% | +$2.08M |
|
|
TBCH
1821
Turtle Beach Corp
TBCH
$228M
| $3.74M | ﹤0.01% |
+253,900
| New | +$2.62M |
|
1822
Omega Flex
OFLX
$289M
| $3.73M | ﹤0.01% |
35,300
-1,200
| -3% | -$114K |
|
1823
KVH Industries
KVHI
$145M
| $3.72M | ﹤0.01% |
416,200
-21,100
| -5% | -$186K |
|
1824
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $3.69M | ﹤0.01% |
73,900
-24,000
| -25% | -$1.19M |
|
1825
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
| $3.68M | ﹤0.01% |
+146,100
| New | +$3.6M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.